Sai Life Sciences - Concurrent Gainers: 8 stocks that gain for 5 days in a row
NiveshIQ
NSE: SAILIFE · Healthcare
Sai Life Sciences Ltd.
₹1,542.30▼ ₹15.20 (-0.98%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SAILIFE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Sai Life Sciences Ltd.
Sai Life Sciences Limited (SAILIFE) is a contract research, development and manufacturing organization (CRDMO) headquartered in Hyderabad, India, offering medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services to global pharma clients. In FY27 Q2, the company reported revenue of ₹2,250 crore and a net income of ₹362 crore, reflecting a 12% YoY revenue growth and a 15% increase in operating margin. Recent developments include a significant equity boost through an ESOP share allotment, expanding the share base and providing additional capital for R&D and capacity expansion. Competitively, Sai Life Sciences differentiates itself with a diversified service portfolio and a strong pipeline of contract manufacturing agreements, positioning i
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,465 Cr +20.40% | ₹1,695 Cr +15.80% | ₹2,192 Cr +29.38% |
| EBITDA Margin | 26.85% | 23.94% | 28.79% |
| Net Profit | ₹83.00 Cr +730.00% | ₹170.13 Cr +104.80% | ₹348.91 Cr +105.08% |
| EPS | – | ₹8.83 | ₹16.63 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Sai Life Sciences - Concurrent Gainers: 8 stocks that gain for 5 days in a row
JK Agri Genetics sells leasehold rights to Sai Life Sciences for ₹19.80 crore
🔒
+ 3 more stories about Sai Life Sciences Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹554 Cr, PAT ₹73 Cr, EPS ₹3.46, EBITDA margin 26.7%. Growth context: revenue YoY +11.7%, PAT YoY +21.2%, revenue QoQ -7.9%, PAT QoQ -29.7%. Street verdict: inline, revenue surprise -2.8%, PAT surprise -4.1%.
Management highlights order wins, deal pipeline, and backlog build as the primary near‑term growth levers, with executio...
FY26 (last completed FY): revenue ₹2, 192 Cr, PAT ₹349 Cr, EBITDA margin 28.8%, EPS ₹16.63. Year-on-year: revenue YoY +2...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Poly Medicure Ltd.Procter & Gamble Health Ltd.Procter & Gamble Hygiene & Health Care Ltd.QMS Medical Allied Services Ltd.Rainbow Childrens Medicare Ltd.Rubicon Research Ltd.Sanofi India Ltd.Senores Pharmaceuticals Ltd.Shilpa Medicare Ltd.Strides Pharma Science Ltd.Sun Pharma Advanced Research Company Ltd.Sun Pharmaceutical Industries Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SAILIFE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SAILIFE alongside your other holdings
Unlock full SAILIFE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Sai Life Sciences Ltd.?
NiveshIQ detects active intelligence signals for Sai Life Sciences Ltd. (SAILIFE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Sai Life Sciences Ltd.?
Sai Life Sciences Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,700,490.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.